Biohaven Therapeutics Ltd.
Registry sponsor category
Industry
- Other names
- Biohaven Therapeutics Ltd.
- Company name
- Biohaven Therapeutics Ltd.
- Organisation type
- Industry
- Registry sponsor category
- Industry
- Publicly traded (proxy)
- No
- Listing at source
- Listed
Related records
Trials (20)
- A Phase 1 Study of BHV-1530 in Advanced Solid Tumors
- A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors
- A Phase 1b Study of BHV-7000 in Participants With Inherited Erythromelalgia
- A Study to Determine if BHV-1400 is Effective and Safe in Adults With IgA Nephropathy
- A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures
- A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
- A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Acceptability, Feasibility, Safety and Efficacy of a Optimized Rehabilitation Program for Treated Patients With Spinal Muscular Atrophy (SMA).
- BHV-7000 Acute Treatment of Bipolar Mania
- BHV-7000 Open-Label Extension Bipolar Mania Study
- Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression
- Efficacy and Safety Trial of BHV-2100 for the Acute Treatment of Migraine
- Long-term Safety and Tolerability of BHV-7000
- Long-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD)
- Real-World Data Study of Troriluzole-Treated Patients With Spinocerebellar Ataxia (SCA) Compared to a Matched Natural History Control
- Study of BHV-1300 in Graves' Disease
- Study of BHV-1400 in IgA Nephropathy
- Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
- Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
- Taldefgrobep Alfa in Adults With Overweight and Obesity